March 23rd is Diabetes Alert Day. It’s a one day “wake-up” call, sponsored by the American Diabetes Association (ADA), for…
Tag: Obesity
A new study, reported by the American Heart Association...
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin) and metreleptin (an analog of the natural hormone leptin)...
The National Institutes of Health provided a research grant of $2.4 million to Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston, to study the link between obesity and high-risk pregnancies caused by preeclampsia and diabetes.
I read this New York Times article, “Childhood Obesity Battle Is Taken Up by First Lady,” which details Michelle Obama’s Let’s…
Amylin Pharmaceuticals, Inc. and Takeda Pharmaceuticals Company Limited announced an agreement to co-develop and commercialize pharmaceutical products for the treatment of obseity and related conditions. Amylin, whose top product, Byetta, had sales of $678.5 million last year. will receive a one-time up-front payment of $75 million from Takeda, the largest pharmaceutical